Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 279

The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.

Inappropriate empirical antibiotic therapy for bloodstream infections based on discordant in-vitro susceptibilities: a retrospective cohort analysis of prevalence, predictors, and mortality risk in US hospitals

Open access
Kadri, Sameer S, Lai, Yi Ling, Warner, Sarah, Strich, Jeffrey R, Babiker, Ahmed, Ricotta, Emily E, Demirkale, Cumhur Y, Dekker, John P, Palmore, Tara N, Rhee, Chanu, Klompas, Michael, Hooper, David C, Powers, John H, Srinivasan, Arjun, Danner, Robert L, Adjemian, Jennifer·2021·The Lancet Infectious Diseases

Abstract

Background: The prevalence and impact of inappropriate empiric antibiotic therapy for bloodstream infections (BSI) is unclear. We aimed to determine the population-level burden, predictors, and mortality risk of in vitro susceptibility-discordant empiric antibiotic therapy (DEAT) among BSI patients. Methods: Inpatients with BSI treated with systemic antibiotics on the day blood cultures were drawn or the following day were identified. DEAT occurred if the isolate was not susceptible in vitro to antibiotic(s) administered on blood culture sampling day. DEAT prevalence by hospital type was calculated using regression tree analysis and predictors were identified using Generalized Estimating Equations. Adjusted odds ratio (aOR) of in-hospital mortality was determined using logistic regression. Findings: At 131 hospitals between 2005–2014, 26,036 assessable BSI patients received empiric therapy on the day of or day after first blood culture collection. Seventeen percent (4,428) received no antibiotics on blood culture day. Of the remaining 21,608 patients, 4,165(19–3%) received DEAT [reliability-adjusted range by hospital type: 16·6(95% CI, 15·0–18·5)% to 21·1(95% CI, 20·1–22·1)%]. Antibiotic-resistant phenotypes strongly predicted DEAT [a0R=9·09(95% CI, 7·68–10·76);p<0·001]. Most DEAT events (73%) and associated deaths (76·8%) occurred among patients with S. aureus and Enterobacteriaceae BSIs. DEAT was independently associated with higher mortality (aOR=1·5[95% CI, 1·4–1·7];p<0·001), a relationship that was unaffected by the presence or absence of resistance or sepsis or septic shock. Interpretation: Approximately one in five BSI patients in U.S. hospitals received DEAT, which was closely associated with antibiotic-resistant pathogens. DEAT decreased survival even among those presenting without sepsis. Earlier identification of bloodstream pathogens and resistance is likely to improve population-level outcomes. Funding: NIH, U.S. CDC, AHRQ

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s1473-3099(20)30477-1

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 34 references

Cited by

See all 279

Metadata

Authors
Kadri, S. S., Lai, Y. L., Warner, S., Strich, J. R., Babiker, A., Ricotta, E. E., Demirkale, C. Y., Dekker, J. P., Palmore, T. N., Rhee, C., Klompas, M., Hooper, D. C., Powers, J. H., Srinivasan, A., Danner, R. L., & Adjemian, J.
Venue
The Lancet Infectious Diseases
Publisher
Elsevier BV
Published
2021-02
Volume
21
Issue
2
Pages
241-251
ISSN
1473-3099 (ISSN-L)
OpenAlex
W3083892815
Cited by
279
References
34
FWCI
17.79
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Inappropriate empirical antibiotic therapy for bloodstream infections based on discordant in-vitro susceptibilities: a retrospective cohort analysis of prevalence, predictors, and mortality risk in US hospitals. https://app.cochat.ai/papers/10.1016/s1473-3099(20)30477-1
The paper
Kadri, S. S., Lai, Y. L., Warner, S., Strich, J. R., Babiker, A., Ricotta, E. E., Demirkale, C. Y., Dekker, J. P., Palmore, T. N., Rhee, C., Klompas, M., Hooper, D. C., Powers, J. H., Srinivasan, A., Danner, R. L., & Adjemian, J. (2021). Inappropriate empirical antibiotic therapy for bloodstream infections based on discordant in-vitro susceptibilities: a retrospective cohort analysis of prevalence, predictors, and mortality risk in US hospitals. The Lancet Infectious Diseases. https://doi.org/10.1016/s1473-3099(20)30477-1

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.